(19)
(11) EP 4 171 539 A1

(12)

(43) Date of publication:
03.05.2023 Bulletin 2023/18

(21) Application number: 20942038.9

(22) Date of filing: 26.06.2020
(51) International Patent Classification (IPC): 
A61K 31/192(2006.01)
A61K 9/24(2006.01)
 A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/20; A61K 9/28; A61K 9/10; A61K 31/55; A61K 31/714
 
C-Sets:
  1. A61K 31/55, A61K 2300/00;
  2. A61K 31/714, A61K 2300/00;
(86) International application number:
PCT/US2020/039916
(87) International publication number:
WO 2021/262196 (30.12.2021 Gazette 2021/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: LA Pharmatech Inc.
Blacksburg, VA 24060 (US)

(72) Inventors:
  • WANG, Jianmin
    Blacksburg, VA 24060 (US)
  • CUI, Geping
    Blacksburg, VA 24060 (US)

(74) Representative: Witthoff Jaekel Steinecke Patentanwälte PartG mbB 
Postfach 1140
52412 Jülich
52412 Jülich (DE)

   


(54) COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE